165 related articles for article (PubMed ID: 8388750)
1. Bradykinin regulates the expression of kininogen binding sites on endothelial cells.
Zini JM; Schmaier AH; Cines DB
Blood; 1993 Jun; 81(11):2936-46. PubMed ID: 8388750
[TBL] [Abstract][Full Text] [Related]
2. The carboxyl terminus of bradykinin and amino terminus of the light chain of kininogens comprise an endothelial cell binding domain.
Hasan AA; Cines DB; Zhang J; Schmaier AH
J Biol Chem; 1994 Dec; 269(50):31822-30. PubMed ID: 7989355
[TBL] [Abstract][Full Text] [Related]
3. High-molecular-weight kininogen is exclusively membrane bound on endothelial cells to influence activation of vascular endothelium.
Hasan AA; Cines DB; Ngaiza JR; Jaffe EA; Schmaier AH
Blood; 1995 Jun; 85(11):3134-43. PubMed ID: 7756645
[TBL] [Abstract][Full Text] [Related]
4. High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage.
Meloni FJ; Gustafson EJ; Schmaier AH
Blood; 1992 Mar; 79(5):1233-44. PubMed ID: 1536948
[TBL] [Abstract][Full Text] [Related]
5. Human high molecular weight kininogen binds to human umbilical vein endothelial cells via its heavy and light chains.
Reddigari SR; Kuna P; Miragliotta G; Shibayama Y; Nishikawa K; Kaplan AP
Blood; 1993 Mar; 81(5):1306-11. PubMed ID: 8443392
[TBL] [Abstract][Full Text] [Related]
6. Low molecular weight kininogen binds to platelets to modulate thrombin-induced platelet activation.
Meloni FJ; Schmaier AH
J Biol Chem; 1991 Apr; 266(11):6786-94. PubMed ID: 2016293
[TBL] [Abstract][Full Text] [Related]
7. Generation of vasoactive peptide bradykinin from human umbilical vein endothelium-bound high molecular weight kininogen by plasma kallikrein.
Nishikawa K; Shibayama Y; Kuna P; Calcaterra E; Kaplan AP; Reddigari SR
Blood; 1992 Oct; 80(8):1980-8. PubMed ID: 1391955
[TBL] [Abstract][Full Text] [Related]
8. Bradykinin decreases T-kininogen synthesis in a rat hepatoma cell line: evidence of bradykinin B2-type receptors.
Raymond P; Bouvier M; Drapeau G; Blais C; Morais R; Adam A
Peptides; 1996; 17(7):1171-6. PubMed ID: 8959752
[TBL] [Abstract][Full Text] [Related]
9. Conformational changes in low molecular weight kininogen alters its ability to bind to endothelial cells.
Hasan AA; Zhang J; Samuel M; Schmaier AH
Thromb Haemost; 1995 Oct; 74(4):1088-95. PubMed ID: 8560418
[TBL] [Abstract][Full Text] [Related]
10. Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells.
Reddigari SR; Shibayama Y; Brunnée T; Kaplan AP
J Biol Chem; 1993 Jun; 268(16):11982-7. PubMed ID: 8505323
[TBL] [Abstract][Full Text] [Related]
11. The binding of high molecular weight kininogen to cultured human endothelial cells.
van Iwaarden F; de Groot PG; Bouma BN
J Biol Chem; 1988 Apr; 263(10):4698-703. PubMed ID: 2832403
[TBL] [Abstract][Full Text] [Related]
12. Domain 3 of kininogens contains a cell-binding site and a site that modifies thrombin activation of platelets.
Jiang YP; Muller-Esterl W; Schmaier AH
J Biol Chem; 1992 Feb; 267(6):3712-7. PubMed ID: 1740422
[TBL] [Abstract][Full Text] [Related]
13. High-molecular-mass and low-molecular-mass kininogens block plasmin-induced platelet aggregation by forming a complex with kringle 5 of plasminogen/plasmin.
Selim TE; Ghoneim HR; Uknis AB; Colman RW; DeLa Cadena RA
Eur J Biochem; 1997 Dec; 250(2):532-8. PubMed ID: 9428707
[TBL] [Abstract][Full Text] [Related]
14. Evidence for existence of two distinct bradykinin receptors on rat mesangial cells.
Bascands JL; Pecher C; Rouaud S; Emond C; Tack JL; Bastie MJ; Burch R; Regoli D; Girolami JP
Am J Physiol; 1993 Mar; 264(3 Pt 2):F548-56. PubMed ID: 8384416
[TBL] [Abstract][Full Text] [Related]
15. Assembly and activation of HK-PK complex on endothelial cells results in bradykinin liberation and NO formation.
Zhao Y; Qiu Q; Mahdi F; Shariat-Madar Z; Røjkjaer R; Schmaier AH
Am J Physiol Heart Circ Physiol; 2001 Apr; 280(4):H1821-9. PubMed ID: 11247797
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel binding site for 125I-Tyr-D-Arg-[Hyp3,D-Phe7,Leu8]bradykinin on epithelial membranes of guinea pig ileum.
Tousignant C; Regoli D; Rhaleb NE; Jukic D; Guillemette G
Eur J Pharmacol; 1992 Mar; 225(3):235-44. PubMed ID: 1325366
[TBL] [Abstract][Full Text] [Related]
17. B1 and B2 kinin receptors on cultured rabbit superior mesenteric artery smooth muscle cells: receptor-specific stimulation of inositol phosphate formation and arachidonic acid release by des-Arg9-bradykinin and bradykinin.
Tropea MM; Gummelt D; Herzig MS; Leeb-Lundberg LM
J Pharmacol Exp Ther; 1993 Feb; 264(2):930-7. PubMed ID: 8382284
[TBL] [Abstract][Full Text] [Related]
18. Bradykinin stimulates production of inositol (1,4,5) trisphosphate in cultured mesangial cells of the rat via a BK2-kinin receptor.
Bascands JL; Emond C; Pecher C; Regoli D; Girolami JP
Br J Pharmacol; 1991 Apr; 102(4):962-6. PubMed ID: 1649661
[TBL] [Abstract][Full Text] [Related]
19. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R).
Joseph K; Ghebrehiwet B; Peerschke EI; Reid KB; Kaplan AP
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8552-7. PubMed ID: 8710908
[TBL] [Abstract][Full Text] [Related]
20. The expression of high molecular weight kininogen on human umbilical vein endothelial cells.
Schmaier AH; Kuo A; Lundberg D; Murray S; Cines DB
J Biol Chem; 1988 Nov; 263(31):16327-33. PubMed ID: 2460446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
